Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer

A. Y. Bedikian; J. Stroehlein; J. Korinek; D. Karlin; M. Valdivieso; G. P. Bodey

doi:10.1097/00000421-198302000-00007

Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer

A. Y. Bedikian, J. Stroehlein, J. Korinek, D. Karlin, M. Valdivieso, G. P. Bodey

Gastroenterology Hepatology & Nutrition

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	45-48
Number of pages	4
Journal	Unknown Journal
Volume	6
Issue number	1
DOIs	https://doi.org/10.1097/00000421-198302000-00007
State	Published - 1983

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1097/00000421-198302000-00007

Cite this

@article{f7145e76c9c7411abd6fddf6a6cac454,

title = "Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer",

author = "Bedikian, {A. Y.} and J. Stroehlein and J. Korinek and D. Karlin and M. Valdivieso and Bodey, {G. P.}",

year = "1983",

doi = "10.1097/00000421-198302000-00007",

language = "English (US)",

volume = "6",

pages = "45--48",

journal = "Unknown Journal",

issn = "1520-4391",

publisher = "American Society of Hematology",

number = "1",

}

TY - JOUR

T1 - Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer

AU - Bedikian, A. Y.

AU - Stroehlein, J.

AU - Korinek, J.

AU - Karlin, D.

AU - Valdivieso, M.

AU - Bodey, G. P.

PY - 1983

Y1 - 1983

UR - http://www.scopus.com/inward/record.url?scp=0020606856&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020606856&partnerID=8YFLogxK

U2 - 10.1097/00000421-198302000-00007

DO - 10.1097/00000421-198302000-00007

M3 - Article

C2 - 6837506

AN - SCOPUS:0020606856

SN - 1520-4391

VL - 6

SP - 45

EP - 48

JO - Unknown Journal

JF - Unknown Journal

IS - 1

ER -

Phase II evaluation of dihydroxyanthracenedione (DHAD, NSC 301739) in patients with metastatic colorectal cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this